79 related articles for article (PubMed ID: 32700624)
1. Perceived susceptibility to developing cancer and screening for colorectal and prostate cancer: A longitudinal analysis of Alberta's Tomorrow Project.
Gilfoyle M; Chaurasia A; Garcia J; Oremus M
J Med Screen; 2021 Jun; 28(2):148-157. PubMed ID: 32700624
[TBL] [Abstract][Full Text] [Related]
2. Perceived susceptibility to developing cancer and mammography screening behaviour: a cross-sectional analysis of Alberta's Tomorrow Project.
Gilfoyle M; Garcia J; Chaurasia A; Oremus M
Public Health; 2019 Dec; 177():135-142. PubMed ID: 31563701
[TBL] [Abstract][Full Text] [Related]
3. Colorectal, cervical and prostate cancer screening in Australians with severe mental illness: Retrospective nation-wide cohort study.
Tuesley KM; Jordan SJ; Siskind DJ; Kendall BJ; Kisely S
Aust N Z J Psychiatry; 2019 Jun; 53(6):550-558. PubMed ID: 30501394
[TBL] [Abstract][Full Text] [Related]
4. Predictors of CRC Stage at Diagnosis among Male and Female Adults Participating in a Prospective Cohort Study: Findings from Alberta's Tomorrow Project.
Ghebrial M; Aktary ML; Wang Q; Spinelli JJ; Shack L; Robson PJ; Kopciuk KA
Curr Oncol; 2021 Nov; 28(6):4938-4952. PubMed ID: 34898587
[TBL] [Abstract][Full Text] [Related]
5. Patterns and predictors of adherence to colorectal cancer screening recommendations in Alberta's Tomorrow Project participants stratified by risk.
Solbak NM; Xu JY; Vena JE; Al Rajabi A; Vaseghi S; Whelan HK; McGregor SE
BMC Public Health; 2018 Jan; 18(1):177. PubMed ID: 29370789
[TBL] [Abstract][Full Text] [Related]
6. The Association Between Religiosity, Spirituality and Colorectal Cancer Screening: A Longitudinal Analysis of Alberta's Tomorrow Project in Canada.
Mirabi S; Chaurasia A; Oremus M
J Relig Health; 2024 Apr; ():. PubMed ID: 38642242
[TBL] [Abstract][Full Text] [Related]
7. Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?
Sirovich BE; Schwartz LM; Woloshin S
JAMA; 2003 Mar; 289(11):1414-20. PubMed ID: 12636464
[TBL] [Abstract][Full Text] [Related]
8. Clinically relevant changes in family history of cancer over time.
Ziogas A; Horick NK; Kinney AY; Lowery JT; Domchek SM; Isaacs C; Griffin CA; Moorman PG; Edwards KL; Hill DA; Berg JS; Tomlinson GE; Anton-Culver H; Strong LC; Kasten CH; Finkelstein DM; Plon SE
JAMA; 2011 Jul; 306(2):172-8. PubMed ID: 21750294
[TBL] [Abstract][Full Text] [Related]
9. Predictors of colorectal cancer screening: a comparison of men and women.
McGregor SE; Bryant HE
Can J Gastroenterol; 2005 Jun; 19(6):343-9. PubMed ID: 15997267
[TBL] [Abstract][Full Text] [Related]
10. Cancer screening in Queensland men.
Carrière P; Baade P; Newman B; Aitken J; Janda M
Med J Aust; 2007 Apr; 186(8):404-7. PubMed ID: 17437394
[TBL] [Abstract][Full Text] [Related]
11. The individual and combined effects of alcohol consumption and cigarette smoking on site-specific cancer risk in a prospective cohort of 26,607 adults: results from Alberta's Tomorrow Project.
Viner B; Barberio AM; Haig TR; Friedenreich CM; Brenner DR
Cancer Causes Control; 2019 Dec; 30(12):1313-1326. PubMed ID: 31535325
[TBL] [Abstract][Full Text] [Related]
12. Prognostic Significance of Digital Rectal Examination and Prostate Specific Antigen in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Arm.
Halpern JA; Shoag JE; Mittal S; Oromendia C; Ballman KV; Hershman DL; Wright JD; Shih YT; Nguyen PL; Hu JC
J Urol; 2017 Feb; 197(2):363-368. PubMed ID: 27569432
[TBL] [Abstract][Full Text] [Related]
13. Implications of false-positive results for future cancer screenings.
Taksler GB; Keating NL; Rothberg MB
Cancer; 2018 Jun; 124(11):2390-2398. PubMed ID: 29682740
[TBL] [Abstract][Full Text] [Related]
14. Clinicians' perceptions of the benefits and harms of prostate and colorectal cancer screening.
Elstad EA; Sutkowi-Hemstreet A; Sheridan SL; Vu M; Harris R; Reyna VF; Rini C; Earp JA; Brewer NT
Med Decis Making; 2015 May; 35(4):467-76. PubMed ID: 25637592
[TBL] [Abstract][Full Text] [Related]
15. The association between Medicare accountable care organization enrollment and breast, colorectal, and prostate cancer screening.
Resnick MJ; Graves AJ; Gambrel RJ; Thapa S; Buntin MB; Penson DF
Cancer; 2018 Nov; 124(22):4366-4373. PubMed ID: 30412287
[TBL] [Abstract][Full Text] [Related]
16. Influence of Age, Health, and Function on Cancer Screening in Older Adults with Limited Life Expectancy.
Schoenborn NL; Huang J; Sheehan OC; Wolff JL; Roth DL; Boyd CM
J Gen Intern Med; 2019 Jan; 34(1):110-117. PubMed ID: 30402822
[TBL] [Abstract][Full Text] [Related]
17. Variation of colorectal, breast and prostate cancer screening activity in Switzerland: Influence of insurance, policy and guidelines.
Ulyte A; Wei W; Dressel H; Gruebner O; von Wyl V; Bähler C; Blozik E; Brüngger B; Schwenkglenks M
PLoS One; 2020; 15(4):e0231409. PubMed ID: 32298325
[TBL] [Abstract][Full Text] [Related]
18. Prostate and Colorectal Cancer Screening Uptake among US and Foreign-Born Males: Evidence from the 2015 NHIS Survey.
Ilunga Tshiswaka D; Donley T; Okafor A; Memiah P; Mbizo J
J Community Health; 2017 Jun; 42(3):612-623. PubMed ID: 27838809
[TBL] [Abstract][Full Text] [Related]
19. Screening for colorectal cancer and prostate cancer: challenges for New Zealand.
Richardson AK; Potter JD
N Z Med J; 2014 Jun; 127(1395):23-30. PubMed ID: 24929690
[TBL] [Abstract][Full Text] [Related]
20. Association of Race and Socioeconomic Status With Colorectal Cancer Screening, Colorectal Cancer Risk, and Mortality in Southern US Adults.
Warren Andersen S; Blot WJ; Lipworth L; Steinwandel M; Murff HJ; Zheng W
JAMA Netw Open; 2019 Dec; 2(12):e1917995. PubMed ID: 31860105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
